Study on how male hormones affect immune cells in glioblastoma
Treatments studied
Part of Cancer clinical trials.
This study looks at how male hormones (androgens) affect the immune cells around glioblastoma tumors. Researchers will analyze tumor tissue left over from surgery to learn more, which may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- You must have a new diagnosis of glioblastoma (a type of brain tumor).
- You must have had surgery to remove part or all of the tumor.
- You must be eligible to receive chemotherapy and radiation therapy.
- You must not have active immune system disorders or infections.
- You must not be taking corticosteroid medications (like dexamethasone).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at proteins in the fluid around the brain and spine of people with glioblastoma to learn more about the tumor and find better ways to diagnose and treat it. You would give samples of fluid, blood, and tumor tissue, and have follow-up care at a specific hospital.
This study looks at how your immune system reacts to brain tumor surgery and standard treatment, using a special dye to help the surgeon see the tumor better. It aims to find out if this approach can improve outcomes for people with glioblastoma.
This study follows people newly diagnosed with glioblastoma to see how certain lab signals (MMP2 and MMP9) match up with MRI scan features. It may help doctors better understand the disease and how it appears on imaging, but it’s mainly observational.
This study looks at whether exposure to pesticides affects how the tumor behaves and how long people live after a glioblastoma diagnosis. By joining, you help researchers learn if environmental factors matter for this brain cancer.
This study looks at whether brain scans (MRI, PET/CT) can help predict the genetic makeup of glioblastoma, without needing more tissue samples. If you join, you'll get advanced imaging to better understand your tumor and guide future treatment decisions.
This study tracks people with glioblastoma (a type of aggressive brain tumor) over time to understand what affects their health and quality of life. If you take part, you'll fill out online surveys to help researchers learn how to improve care.
Hear when a new Glioblastoma (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.